
Ogliz 0.3mg Tablet
Marketer
Lia Life Sciences Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Ogliz 0.3mg Tablet
Glimepiride 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose following meals, particularly when dietary modifications and other similar medications prove insufficient. Administer this tablet immediately before meals; dosage and frequency are determined by your physician for optimal blood sugar control. Discontinue use only under medical supervision; abrupt cessation may elevate blood sugar, potentially causing serious complications like renal impairment and vision loss. This medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial. Common side effects include gas, abdominal discomfort, appetite changes, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While unlikely to cause hypoglycemia alone, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; table sugar is ineffective in this context. Inform your physician of any kidney or liver conditions before starting treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women require medical consultation prior to use. Always disclose all medications to ensure safe interaction. Limit alcohol consumption due to potential hypoglycemia risk.
Primary Ingredients of Ogliz 0.3mg Tablet
No text provided to rephrase.
Uses of Ogliz 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Ogliz 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Ogliz 0.3mg Tablet should be taken on an empty stomach.
Common Side effects of Ogliz 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Ogliz 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the 0.3mg Ogliz tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Ogliz 0.3mg Tablet works:
Glycemia control is achieved with Ogliz 0.3mg tablets, an antidiabetic medication. These tablets work by suppressing intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ogliz 0.3mg Tablet and alcohol is not recommended due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Ogliz 0.3mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; however, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Ogliz 0.3mg Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ogliz 0.3mg Tablet.
KidneyCAUTION
For individuals with severe kidney impairment, administering Ogliz 0.3mg tablets requires careful consideration. Dosage modification of Ogliz 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, 0.3mg Ogliz tablets require careful administration. Dosage modification of 0.3mg Ogliz tablets may be necessary. Physician consultation is recommended.
What if you forget to take Ogliz 0.3mg Tablet :
Omit any missed Ogliz 0.3mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Ogliz 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
